Suppr超能文献

肺移植:适应证与禁忌证

Lung transplantation: indications and contraindications.

作者信息

Weill David

机构信息

Weill Consulting Group, New Orleans, LA, USA.

出版信息

J Thorac Dis. 2018 Jul;10(7):4574-4587. doi: 10.21037/jtd.2018.06.141.

Abstract

The selection of appropriate recipients for lung transplantation is an evolving discipline. As experience with the procedure has developed over the last decades, the identification of transplant candidates has also changed as transplant centers strive to safely provide the therapy to as many patients possible. The International Society for Heart and Lung Transplantation (ISHLT) has developed three editions of recipient selection guidelines. Published in 1998, 2006, and 2015, these guidelines represented the best information relevant to the appropriate selection of lung transplant candidates. A discussion of areas supported by the most robust scientific data will be undertaken, but in many aspects of recipient selection, there is a paucity of data upon which to rely. Therefore, it is ultimately the prerogative and responsibility of individual centers to determine, after carefully weighing the best evidence available, whether a patient is deemed a suitable candidate at a specific program. All possible indications and contraindications for transplantation will be reviewed with attention also given to the appropriate timing of referral and listing of patients with advanced lung disease to a transplant center.

摘要

为肺移植选择合适的受者是一门不断发展的学科。在过去几十年里,随着肺移植手术经验的积累,由于移植中心努力安全地为尽可能多的患者提供该治疗,移植候选者的识别标准也发生了变化。国际心肺移植学会(ISHLT)已制定了三版受者选择指南。这些指南分别于1998年、2006年和2015年发布,代表了与肺移植候选者合适选择相关的最佳信息。本文将对有最确凿科学数据支持的领域进行讨论,但在受者选择的许多方面,可供依赖的数据很少。因此,在仔细权衡现有最佳证据后,最终由各个中心自行决定某一患者在特定项目中是否被视为合适的候选者。本文将对所有可能的移植适应证和禁忌证进行综述,同时也会关注晚期肺病患者转诊和列入移植中心名单的合适时机。

相似文献

1
Lung transplantation: indications and contraindications.
J Thorac Dis. 2018 Jul;10(7):4574-4587. doi: 10.21037/jtd.2018.06.141.
2
[Selection of lung transplant candidates in France in 2019].
Rev Mal Respir. 2019 Apr;36(4):508-518. doi: 10.1016/j.rmr.2018.03.009. Epub 2019 Apr 19.
4
Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation.
J Heart Lung Transplant. 2021 Nov;40(11):1349-1379. doi: 10.1016/j.healun.2021.07.005. Epub 2021 Jul 24.
5
Indications for lung transplant referral and listing.
J Thorac Dis. 2019 Sep;11(Suppl 14):S1708-S1720. doi: 10.21037/jtd.2019.05.09.
6
[Indications of lung transplantation: Patients selection, timing of listing, and choice of procedure].
Rev Pneumol Clin. 2016 Feb;72(1):87-94. doi: 10.1016/j.pneumo.2014.11.003. Epub 2015 Feb 26.
7
Current trends in candidate selection, contraindications, and indications for lung transplantation.
J Thorac Dis. 2021 Nov;13(11):6514-6527. doi: 10.21037/jtd-2021-09.
8
Lung transplantation: a review of the optimal strategies for referral and patient selection.
Ther Adv Respir Dis. 2019 Jan-Dec;13:1753466619880078. doi: 10.1177/1753466619880078.
9
Timing it right: the challenge of recipient selection for lung transplantation.
Ann Transl Med. 2020 Mar;8(6):408. doi: 10.21037/atm.2019.11.61.

引用本文的文献

1
Optimizing patient outcomes in interstitial lung disease through pre- and post-transplant management strategies.
World J Transplant. 2025 Sep 18;15(3):101866. doi: 10.5500/wjt.v15.i3.101866.
2
Transition to Advanced Heart Failure: From Identification to Improving Prognosis.
J Cardiovasc Dev Dis. 2025 Mar 17;12(3):104. doi: 10.3390/jcdd12030104.
5
Improved Results Over Time With Bridge-to-Lung Transplantation: A 10-Year Experience of a Single High-Volume Center.
Transpl Int. 2025 Jan 30;38:13944. doi: 10.3389/ti.2025.13944. eCollection 2025.
6
Rituximab therapy in severe connective tissue disease associated interstitial lung disease: A retrospective single-centre observational study.
Afr J Thorac Crit Care Med. 2024 Oct 14;30(3):e1431. doi: 10.7196/AJTCCM.2024.v30i3.1431. eCollection 2024.
7
Venopulmonary extracorporeal membrane oxygenation for right ventricular support as a bridge to lung transplantation: A narrative review.
SAGE Open Med. 2024 Oct 16;12:20503121241275410. doi: 10.1177/20503121241275410. eCollection 2024.
9
Size-matching in lung transplantation by computed tomography for end-stage interstitial disease: a retrospective analysis.
J Thorac Dis. 2024 Jun 30;16(6):3685-3695. doi: 10.21037/jtd-23-1586. Epub 2024 Jun 17.
10
Lung Transplantation in the United States for COVID-19 Related Lung Disease During the Pandemic.
Lung. 2024 Oct;202(5):723-737. doi: 10.1007/s00408-024-00724-z. Epub 2024 Jun 27.

本文引用的文献

2
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
N Engl J Med. 2014 May 29;370(22):2083-92. doi: 10.1056/NEJMoa1402582. Epub 2014 May 18.
3
The equitable allocation of deceased donor lungs for transplant in children in the United States.
Am J Transplant. 2014 Jan;14(1):178-83. doi: 10.1111/ajt.12547. Epub 2013 Dec 12.
4
Combined lung and liver transplantation: analysis of a single-center experience.
Liver Transpl. 2014 Jan;20(1):46-53. doi: 10.1002/lt.23770. Epub 2013 Nov 30.
6
Lung transplantation for interstitial lung diseases and pulmonary hypertension.
Semin Respir Crit Care Med. 2013 Jun;34(3):281-7. doi: 10.1055/s-0033-1348462. Epub 2013 Jul 2.
7
Lung transplantation after lung volume reduction surgery.
Transplantation. 2013 Aug 27;96(4):421-5. doi: 10.1097/TP.0b013e31829853ac.
8
Simultaneous thoracic and abdominal transplantation: can we justify two organs for one recipient?
Am J Transplant. 2013 Jul;13(7):1806-16. doi: 10.1111/ajt.12291. Epub 2013 May 29.
9
Lung transplant outcomes in cystic fibrosis patients with pre-operative Mycobacterium abscessus respiratory infections.
Clin Transplant. 2013 Jul-Aug;27(4):523-9. doi: 10.1111/ctr.12140. Epub 2013 May 26.
10
Outcomes in systemic sclerosis-related lung disease after lung transplantation.
Transplantation. 2013 Apr 15;95(7):975-80. doi: 10.1097/TP.0b013e3182845f23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验